Last reviewed · How we verify
Aspirine
At a glance
| Generic name | Aspirine |
|---|---|
| Sponsor | Lee's Pharmaceutical Limited |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Evaluation of Low Dose Colchicine and Ticagrelor in Prevention of Ischemic Stroke in Patients With Stroke Due to Atherosclerosis (PHASE3)
- Study of Pembrolizumab, Radiation and Immune Modulatory Cocktail in Cervical/Uterine Cancer (PHASE2)
- Painless Local Anaesthesia With Bicarbonate Admixture (PHASE2)
- First Approach for Aspirin Misuse Objective Screening (NA)
- Effectiveness of Night Administration of Low Dose Aspirin in Hypertensive Patients (PHASE3)
- Zainidip in Renal Artery Stenosis (PHASE4)
- ELIGIBLE (Efficacy of Left atrIal Appendage Closure After GastroIntestinal BLEeding) (PHASE3)
- Platelets Induced Vasodilation, in Vitro and in Vivo Study (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Aspirine CI brief — competitive landscape report
- Aspirine updates RSS · CI watch RSS
- Lee's Pharmaceutical Limited portfolio CI